Posts by Christopher
The Geneva Patient: Another Case of HIV Remission
A new case of HIV remission may become the sixth example of an HIV cure. The 2020s have proven to be a remarkable decade for HIV cure advancements, with several significant cases. The Dusseldorf Patient has been declared cured, the New York Patient achieved remission through an innovative haplo-cord transplant, and the City of Hope…
Read MoreGenetic Engineering & Biotechnology News: AGT Spins Out Addimmune, Focusing on Functional HIV Cure
Original Post on Genengnews By: Alex Philippidis According to CEO Jeff Galvin, the cell and gene therapy developer hopes its Addimmune spinout will pick up where AGT leaves off in developing a one-time treatment for HIV, in light of positive early data. A leading developer of gene and cell therapies is spinning out a new company focused on…
Read MorePrecision Medicine Online: American Gene Technologies Spinoff Sets Sights on Advancing Cell Therapy for HIV
Addimmune was recently featured in Precision Medicine Online. The article underscores the company’s commitment to addressing the challenges of HIV, featuring AGT103-T as a potential cure and its role in reshaping the landscape of antiretroviral therapy. Access to the desired content is restricted by a paywall. To proceed to the publisher’s website, kindly follow the…
Read MorePerspectives on HIV: Viral Reservoirs
Why does HIV infect people for their entire lives? We encounter countless unique viruses every day without falling ill, so what sets HIV apart? Why does this virus cause a lifelong infection marked by constant medication and social stigma? To form a solution, we need to start by understanding the problem. By studying how HIV…
Read MoreCityBiz: Interview with Jeff Galvin, CEO & Founder of American Gene Technologies and Addimmune
Original Post on Citybiz BY Edwin Warfield Jeff Galvin is the CEO and Founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken…
Read MoreGene therapy for HIV: How does it work?
What is gene therapy and why is it useful for HIV infection? Gene therapy is a technique used by scientists and doctors to deliver medicinal genes to a patient’s cells. With today’s technological advancements, it is possible to identify the malfunctioning gene responsible for a given disease and then correct it using advanced genetic tools.…
Read MoreRaif Derrazi Interviews Jeff Galvin on HIV Clinical Trial Updates & Addimmune
CEO Jeff Galvin joins HIV activist and Youtube creator Raif Derrazi to discuss the launch of Adimmune™ – a new HIV-focused spinoff company that will focus solely on advancing an HIV cure, building upon more than a decade of work by American Gene Technologies® (AGT™). Galvin provides insights on data from AGT’s HIV Phase I…
Read MoreGene Therapy and Lifeblood: Sickle Cell
Gene therapy has emerged as a logical approach for treating lifelong conditions, be it inherited disorders or persistent viral infections. When faced with a lifelong condition, would you rather take a lifetime of pills, or would you prefer living with modified versions of your own cells that can effectively manage the disease for you? Thanks…
Read MoreChallenge the narrative: HIV is a curable condition
If HIV is incurable, why have some people been cured? Under normal circumstances, exposure to HIV leads to infection, which inevitably leads to AIDS after years of virus-mediated destruction of the immune system. However, there are some exceptions to this rule, and by studying these exceptions, researchers have successfully cured HIV infection on multiple occasions.…
Read More